The lot history records have been reviewed with special attention to the manufacturing and inspection of this product and the product was found to have met all specifications prior to shipment.There is no indication for a manufacturing-related issue.Based on the evaluation of the returned sample it is confirmed that the deployment mechanism had been actively used and that the stent could not be deployed because a force transmitting component broke at the proximal end.Increased friction in the catheter section was considered as reason for increased release force and subsequent fracture of a force transmitting component.As a result of the investigation performed the complaint is confirmed.However, a definite root cause for the reported event could not be determined.Potential factors that could have led or contributed to a deployment failure have been evaluated.Therefore, previous investigations of similar complaints have been reviewed.The reported event may be related to a difficult anatomy as highly tortuous and calcified vessels may lead to increased friction and subsequent release force increase.In reviewing the labeling supplied with this product it was found that the instructions for use (ifu) sufficiently addressed the potential risk.The ifu states: "do not constrict the delivery system during stent deployment.If excessive force is felt during stent deployment, do not force the stent system.Remove the stent system and replace with a new unit." and "examine the stent system for any damage.If it is suspected that the sterility or performance of the stent system has been compromised, the device must not be used.".
|